image2 (IMAGE)
Caption
Fig.2 The resulting αAβ-Gas6 clears Aβ oligomers and fibrils without causing neurotoxicity (a-b, neurons: red, and fragmented axons: yellow) and proinflammatory responses (c, TNF release), which are conversely exacerbated by the treatment of an Aβ-targeting monoclonal antibody (Aducanumab).
Credit
Gliabiology Lab & Kim Lab of Immunotherapy
Usage Restrictions
N/A
License
Original content